Lataa...
Does the development of new medicinal products in the European Union address global and regional health concerns?
BACKGROUND: Since 1995, approval for many new medicinal products has been obtained through a centralized procedure in the European Union. In recent years, the use of summary measures of population health has become widespread. We investigated whether efforts to develop innovative medicines are focus...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2010
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3017015/ https://ncbi.nlm.nih.gov/pubmed/21172012 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1478-7954-8-34 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|